Arterial stiffness in patients with non-diabetic chronic kidney disease (CKD)

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 1, 2009, Pages 57-62

  Matsuda, Nami ^a   Takei, Takashi ^a   Fujiu, Ayuko ^a   Ogawa, Tetsuya ^a   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Arterial stiffness; Cardiovascular disease; Chronic kidney disease; Nephrosclerosis; Pulse wave velocity

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; MALE; NEPHROSCLEROSIS; PREVALENCE; PROTEIN BLOOD LEVEL; PULSE WAVE; TONOMETER;

EID: 67549105760     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E602     Document Type: Article

References (30)

1. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med, 2000; 342:1478-1483
2. Guerub AP, London GM, Marcharis SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant, 2000; 15:1014-1021
3. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension, 2001; 38:938-942
4. Sarnak MJ, Levey AS: Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis, 2000; 35:S117-S131
5. Wang MC, Tsai WC, Chen JY, Huang JJ: Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis, 2005; 45:494-501
6. Ohta Y, Fujii K, Arima H, Matsumura K, Tsuchihashi T, Tokumoto M, Tsuruya K, Kanai H, Iwase M, Hirakata H, Iida M: Increased renal resistive index in atherosclerosis and diabetic nephropathy assessed by Doppler sonography. J Hypertens, 2005; 23:1905-1911
7. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2005; 67:2089-2100
8. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res, 2002; 25:359-364
9. Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T: Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res, 2004; 27:471-477
10. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis, 2007; 50:927-937
11. Covic A, Haydar AA, Bhamra-Ariza P, Gusbeth-Tatomir P, Goldsmith DJ: Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol, 2005; 18:388-396
12. Covic A, Gusbeth-Tatomir P, Goldsmith DJ: Arterial stiffness in renal patients: an update. Am J Kidney Dis, 2005; 45:965-977
13. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int, 1999; 56:2214-2219
14. Kawamoto R, Kohara K, Tabara Y, Miki T, Ohtsuka N, Kusunoki T, Yorimitsu N: An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med, 2008; 47:593-598
15. Nitta K, Akiba T, Suzuki K, Uchida K, Ogawa T, Majima K, Watanabe R, Aoki T, Nihei H: Assessment of coronary artery calcification in hemodialysis patients using multidetector spiral CT scan. Hypertens Res, 2004; 27:527-533
16. Kim EJ, Park CG, Park JS, Suh SY, Choi CU, Kim JW, Kim SH, Lim HE, Rha SW, Seo HS, Oh DJ: Relationship between blood pressure parameters and pulse wave velocity in normotensive and hypertensive subjects: invasive study. J Hum Hypertens, 2007; 21:141-148
17. Watanabe S, Okura T, Kitami Y, Hiwada K: Carotid hemodynamic alterations in hypertensive patients with insulin resistance. Am J Hypertens, 2002; 15:851-856
18. Seo HS, Kang TS, Park S, Park HY, Ko YG, Choi D, Jang Y, Chung N: Insulin resistance is associated with arterial stiffness in nondiabetic hypertensives independent of metabolic status. Hypertens Res, 2005; 28:945-951
19. Sarafidis PA, Lasaridis AN, Nilsson PM, Pagkalos EM, Hitoglou-Makedou AD, Pliakos CI, Kazakos KA, Yovos JG, Zebekakis PE, Tziolas IM, Tourkantonis AN: Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase. J Hypertens, 2004; 22:1769-1777
20. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med, 1996; 334:374-381
21. Safar ME: Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system. J Hypertens, 2005; 23:673-681
22. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation, 1998; 97:425-428
23. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE: C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon. Circulation, 1999; 100:96-102
24. Hoang K, Tan JC, Derby G, Blouch KL, Masek M, Ma I, Lemley KV, Myers BD: Determinants of glomerular hypofiltration in aging humans. Kidney Int, 2003; 64:1417-1424
25. Braun J, Asmus HG, Holzer H, Brunkhorst R, Krause R, Schulz W, Neumayer HH, Raggi P, Bommer J: Long-term comparison of a calcium-free phosphate binder and calcium carbonate-phosphorus metabolism and cardiovascular calcification. Clin Nephrol, 2004; 62:104-115
26. Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW: Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant, 2005; 20:1140-1147
27. Agata J, Nagahara D, Kinoshita S, Takagawa Y, Moniwa N, Yoshida D, Ura N, Shimamoto K: Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension. Circ J, 2004; 68:1194-1198
28. Shinohara K, Shoji T, Kimoto E, Yokoyama H, Fujiwara S, Hatsuda S, Maeno T, Shoji T, Fukumoto S, Emoto M, Koyama H, Nishizawa Y: Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus. J Atheroscler Thromb, 2005; 12:205-210
29. Ozaki K, Kubo T, Imaki R, Shinagawa H, Fukaya H, Ohtaki K, Ozaki S, Izumi T, Aizawa Y: The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia. J Atheroscler Thromb, 2006; 13:216-219
30. Yamagata K, Iseki K, Nitta K, Imai H, Iino Y, Matsuo S, Makino H, Hishida A: Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol, 2008; 12:1-8